3 stories mentioning DOXUpdated 2d ago
Every FINWIRES story that references DOX, newest first.
Amdocs (DOX) has an average rating of overweight and mean price target of $84.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our price target to $52 from $85, 7x our FY 26 (Sep.) EPS estimate, below DOX's three-year average (~12x) on macroeconomic uncertainty and emerging AI competition. We cut our FY 26 EPS view by $0.06 to $7.37 and lower FY 27's by $0.18 to $7.83. While Q2 results printed in line with consensus and FY 26 guidance midpoints were maintained, our primary takeaway from earnings was management's more aggressive roadmap of AI transformation, which should bring margin pressure and looks to us more like defense than offense. While 12-month-backlog growth of 2.6% was similar to recent quarters, Managed Services (65% of Q2 sales) saw growth of just 1.6%, representing a continued, steady decline from a recent peak of 4.1% in Q3 FY 25. We view this as a potential validation of AI competition fears. We expect more investments in autonomous delivery to pressure margins/cash flow, and despite some signs of early traction (five customers have signed up for aOS), sales from DOX's AI platforms remain immaterial.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:DOX's Mar-Q results slightly exceeded expectations, with sales of $1.172B (+3.9% Y/Y) and non-GAAP EPS of $1.78 beating consensus views of $1.166B and $1.76, respectively. Constant currency sales growth again decelerated, coming in at 2.2% from the prior quarter's 3.5% rate, with managed services (65% of sales) slowing to 1.6% growth from 2.3% growth in Q1. Management narrowed its FY 26 guidance ranges, with sales growth now expected at 2.6%-4.6% (vs. prior 1.5%-5.5%) and EPS growth expected at 5%-7% (vs. prior 4%-8%). 12-month backlog grew 2.6% Y/Y to $4.28B, offering strong support for the company's modest sales growth outlook with minimal reliance on shorter-term discretionary work (which has been under pressure amid the uncertain macro environment). CFO Tamar Rapaport-Dagin will be leaving the company, with Tal Rozenfeld (Head of Finance) taking over effective June 2026, though we expect no material operating impact from the change.
